Blue Horseshoe Stocks: Updates on IGC, MY, NEWL & Extended Watchlist

Extended Watchlist Winners:
Yesterday’s Extended Watchlist unearthed a couple of gems, so let’s start things off today by congratulating those who were able to capitalize on the ample chances to profit that these plays offered:

India Globalization Capital, Inc. (IGC)

IGC rewarded us for our attention with a bullish session that saw its low before 10am and ran into the close. From a daily low of 1.27, the stock pushed its way all the way up to 2.08, a highly respectable 64% intraday move, with a couple of vital swings in between that could have been timed for even more opportunities.

It did so on roughly 40x its 3-month average volume, giving us another clue that this could be a play with continued momentum. Even now, in early pre-market trading the stock has run as high as the 2.20’s so we’ll be on the lookout for one of two things; either the momentum carries it further, or profit-taking causes a pullback, in which case we’d be watching for a classic dip-and-rip on the rebound.

If the severity of yesterday’s swing action on the chart spills over into today, there could in fact be several intraday moves that we may be able to use to our advantage.

China Ming Yang Wind Power Group Limited (MY)

The other success from yesterday’s watchlist was MY. This play was one of the most gradual gainers you’re likely to see. Following its daily low of 2.83 it stair-stepped its way into the close at its high of day at 3.63. That was good for a solid intraday gain of 28% on more than four times the 3-month average volume.

Much like the previously mentioned play, we’ll be looking for MY to possibly continue its upward movement today after settling down from what appears to be another pre-market gap-up. In morning trading so far, the stock has pushed past yesterday’s high; if we see another dip-and-rip today it will be the third consecutive session in which one has occurred.


NewLead Holdings Ltd. NEWL

As we stated yesterday, we’ve been following NEWL for awhile now, and the recovery we’re seeing off of its recent bottom of .3867 has sprouted into a multi-day run that has been nothing short of impressive.

The stock gained even more ground following our morning report, wherein we mentioned that we wanted to see a break of the pre-market high of 4.20. We got that and more, as NEWL went on to reach 4.79 with volume 15x greater than normal.

Modest intraday gains of 26% were possible with NEWL yesterday, but the truly impressive figure is the five-session increase we’ve now witnessed from the above-mentioned low to yesterday’s high, which stood at 1138%

The stock also landed us in the Penny Stock Rumble for the day’s largest dollar-volume pick, with more than $160M worth of shares changing hands on the day.


Added Comments:

The markets as a whole had their best day all month on Wednesday, and it translated into gains for us. The overall sentiment is that conditions should remain favorable as long as the Fed holds off on any changes in interest rates. Following the revelation that there would be no increase at this time, the following four major players began to run:

FB, GOGO, PCLN, TSLA

We’ll be monitoring the Options Call action on all of these big-board plays for continued momentum today.


Extended Watchlist:
RENN, ROYL, CTIC, NIHD, LIQD

OXBT, PROW, RNN, BYD & Extended Watchlist

Oxygen Biotherapeutics, Inc. OXBT

Our readers who have been with us since October will remember OXBT, and that we were fortunate enough to catch it at a low of 1.46 before it steamrolled its way up to 11.40, affording us the chance at gains of 681% We re-tagged it on December 19thafter the consolidation off of the initial spike brought the stock back to find a bottom at 4.20. Our timing on that alert ended being spot-on, as the pattern reversed and OXBT began to ascend once more. As of Friday, the stock had reached a high of 7.40, which represents a gain of 76% from the recent 4.20 low.High volume and a strong close at 7.35 for Friday’s session will ensure OXBT a spot on our watchlists as we kick off this new trading week.


Progress Watch Corp. PROW

We pointed out the Golden Cross in progress for PROW on Friday, and despite already having witnessed gains in excess of 515% from .0065 to Thursday’s high of .04 (Initial alert- 12/20/13) we were able to reap further profits as the stock continued to uptrend, topping out at .048 and settling back only slightly to close at .0472. That high pushed our max gains on PROW to 638% in less than a month’s time. Congrats to anyone to has been able to take advantage of this rapid-gainer.

As is the case with any stock that rises so quickly, we’ll need to execute our trades with tight stops, and be on the lookout for signs of a reversal while still remaining open to the possibility of a continued breakout.


Rexhan Pharmaceuticals, Inc. RNN

We’ve followed RNN from December 11th (Low .4026) onward, and have been duly rewarded for our persistence. Friday, we reminded everyone to be on the lookout for more solid gains, as we had already followed the stock up over 90% and were witnessing some heavy pre-market trading pushing the price even higher. RNN would go on to touch a new high for us at 1.19, which represents a gain of 196% from our initial alert low from just a month ago.

This took place on well over 15x the 3mo. average volume, with a healthy close at 1.14, so we’ll be watching RNN carefully today. Like our previously mentioned plays, RNN has been gaining a lot of ground over a short period of time, and should be monitored closely. Perhaps more so than the others, a quick peek at the chart shows it beginning to look overbought. Vigilance is key! In the event of a pullback, we’d like to see RNN hold support somewhere above the .80-level.


Boyd Gaming Corp. BYD

We want to add BYD to our watchlist today. We haven’t mentioned this one before, but are interested in both the building chart, and the sector in which the company operates. BYD operates over twenty gaming entertainment properties across Nevada, New Jersey, Illinois, Indiana, Iowa, Kansas, Louisiana and Mississippi.

Gaming stocks were a hot ticket in 2013, and with online gaming now being permitted in Nevada, Delaware, and New Jersey, some folks believe that national regulation is ‘in the cards’. The gaming sector, both online and brick-and-mortar, is going to be one to watch intently in 2014.


Extended Watchlist:
BLDR, AAPL, GOGO

TGRO, GOGO, IMUC & Extended Watchlist

Tiger Oil & Energy, Inc. TGRO

TGRO continued to push itself to new highs on Tuesday, as the stock we’ve followed from a low of .36 (12/09) reached 1.47, extending our total possible gain in just a few weeks to 308%

We’ve obviously been extremely pleased with the performance of this pick, but as is the case with any stock that sees gains this large is so small a time-frame, it is by this point that one usually considers taking profits.

For more adventurous folks who might want to leave something on the table, we would suggest the possibility of using a stop-loss, in this case, the bottom of the previous session’s candle at 1.00.


Gogo, Inc. GOGO

GOGO began to rebound on Tuesday after a recent consolidation, holding support and bouncing off of the 50DMA. Many of you will recall our coverage of this popular tech play dating back to September 16th, when we caught it as low as 14.79. It went on to hit a high of 35.77, gaining 142% before the subsequent pullback we just mentioned occurred.

We want to keep an eye on GOGO, now that it has bounced off the $23-range, and is making its way back up, with pre-market trades currently going off above $26.

As far as options trading ideas for GOGO, we are interested in the January or February $30 Calls. For example, the February Calls previously closed at 1.70. If GOGO returned to $36 by 02/22 , those contracts could be trading in the $6 area, which would be good for more than a 250% gain from current levels. .



Extended Watchlist Winners

As is usually the case, we had a few picks from off of our extended watchlist that presented opportunities on Tuesday.

Bioanalytical Systems, Inc. BASI

Daily Range: 2.75-3.80  Gained: 38%

Noah Education Holdings, Ltd. NED

Daily Range: 2.34-2.56  Gained: 9%

ImmunoCellular Therapeutics, Ltd. IMUC

Daily Range: .96-1.09  Gained: 14%

Note: IMUC appears ready to continue its run today, gapping up in pre-market trading. Stay on top of this one, as several key chart indicators are beginning to look favorable. The RSI is starting to come off of being heavily oversold, and the MACD appears ready for a turnaround. As we’ve pointed out below, there is a large gap on the chart, the filling of which would spell significant gains providing it can break through the 1.20-range. We’ll be certain to have this one on our radars in the days and weeks to come.


Extended Watchlist:
ARIA, SPCHB, EROC, GNK

CNAT, GOGO, UNIS, CAMT & Extended Watchlist

Conatus Pharmaceuticals, Inc. CNAT

We caught CNAT on our scanner this morning, and is definitely a stock we’d like to keep an eye on today, following an FDA-related announcement regarding a drug that the company has under development receiving “Orphan Drug” status. FDA plays have provided us with countless opportunities in the past, especially when the news is untraded upon, so we’ll be interested to see how well CNAT fares today as a result.

SAN DIEGO, Dec. 2, 2013 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (CNAT), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Conatus’ drug candidate emricasan for the treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end-stage liver disease. The FDA’s Orphan Drug Designation program is intended to encourage the development of drugs and biologics that may provide benefit to patients suffering from rare diseases or conditions.

Conatus is developing emricasan, a first-in-class, orally active caspase protease inhibitor designed to reduce the activity of enzymes that mediate inflammation and cell death (or apoptosis), for the treatment of patients with chronic liver disease and significant unmet medical need.


GOGO, Inc. GOGO

We have been hot on the trail of GOGO since our first mention on Monday Sept. 16th when it was trading as low as 14.79. We witnessed the stock’s 52-wk high a few weeks later on Nov. 14th (31.55), and then it consolidated to find support at 24.24.

Yesterday, GOGO re-established its 52-wk high at 31.65, and appears to want to gap up and continue its run today. This morning, the company has news out concerning the green light is has received to install its wifi satellite technology on Boeing 747 aircraft. and we’ve seen pre-market trades going off as high as 32.75. From our original alert price, that marks registers as a 121% gain. Heading into today’s session, we’d like to see the previous 52-wk high of 31.55 hold as support on any future pullbacks.

ITASCA, Ill., Dec. 2, 2013 /PRNewswire via COMTEX/ — Gogo (NASDAQ: GOGO), the world leader of in-flight connectivity and a pioneer in wireless in-flight digital entertainment solutions, passed a key milestone in launching its international connectivity service by receiving an STC to install its Ku-satellite technology on Boeing 747-400 aircraft.

Gogo will begin testing the new service immediately and plans to offer the service for customer usage by the first quarter of 2014. The technology will give travelers and crew access to the Internet. The service will also offer passengers Gogo Vision, Gogo’s wireless in-flight entertainment service.


Unilife Corp. UNIS

UNI hits our radar screens as another play with fresh news and a chart that is gapping up premarket. UNIS has a potentially lucrative arrangement in the works with European Pharma giant, Novartis.

YORK, Pa., Dec. 2, 2013 /PRNewswire/ — Unilife Corporation (“Unilife” or “Company”) (NASDAQ: UNIS, ASX: UNS) today announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis’ targeted early-stage pipeline drugs.

Under this agreement, Unilife will supply Novartis with a customized delivery device, consisting of syringe, needle, tubing, controller and pump, to enable administration of a novel investigational Novartis drug into a targeted organ in clinical trials. Unilife has granted Novartis an option for exclusivity under this agreement.



Camtek, Ltd. CAMT

Yesterday wasn’t the first time we’ve mentioned CAMT on our extended watchlist only to see the stock turn in an impressive performance; last Monday, we tagged CAMT as a possible runner, and subsequently witnessed a pop from 4.11-5.29 (+29%). In a repeat of that scenario, yesterday we saw the stock trade from a low of 4.20 on up to 5.75, for a possible gain of 37%

Cheers to anyone who was able to take advantage of those very timely alerts!


Extended Watchlist:
IACH, OMED, ETRM, FRO, DGLY, NAVB

GOGO, AZC, PHOT, CBMX & Extended Watchlist

GOGO, Inc.  GOGO

Yesterday after appearing as a focus in our morning report, GOGO responded by posting yet another solid performance. After sinking to a daily low of 27.11, we witnessed a 12% intraday move to 30.26 on twice the 3mo. average volume. That was followed by a strong close, as it held the majority of its gains at 29.70.

The following screenshot captures the activity of the options we were interested in: The 01/18 $30 Calls made a 78% intraday move, and with the way GOGO is trading up pre-market, it’s fair to expect these contracts to be pushed even deeper into the money, adding to our already impressive chances for profit.


Augusta Resources Corp.  AZC

AZC also had a positive showing after yesterday’s report; the stock traded in a range from 1.06-1.25, giving us the opportunity to bank up to an 18% gain. We were correct in assuming that this recovery play was worth our attention, and a return to pre-11/20 levels would still mean significant gains from where it sits now.


Growlife, Inc. PHOT

We’ve continuously covered PHOT for over a year now, and the stock has definitely brought us some prime opportunities for sizable gains, as a quick glance at the chart will show. A recent dip back to the .06-range has been immediately followed by a significant bounce. We are looking at resistance sitting at .095 and from there it has a good chance to re-test recent highs.

We’d like to see higher lows today to confirm that PHOT is indeed back on an uptrend.

To take an even more in-depth look at the PHOT chart, view the video we prepared this morning:


CombiMatrix Corp. CBMX

CBMX came off of yesterday’s extended watchlist to have a big day. The stock opened at 2.48, and would ultimately touch a high of 4.44, which was good for a 79% intraday rip. This came on roughly 48X times the 3mo. average volume, so a stock with this kind of momentum flowing through it will surely continue to be on our watchlist as we close out the week.


Extended Watchlist:
MRIB, ARIA, USU, PVG, POZN, ATRM, ONVO, OIBR,

Get Our FREE Daily Reports!